Zim Laboratories shareholders and shareholding pattern
NSE: ZIMLABBSE: 541400Pharmaceuticals & BiotechnologySmall Cap
Last close ₹126.22down ₹5.90 (4.47%)BSE ₹126.60
Share price at the NSE close on 23 Oct 2026. Previous close ₹132.12.
52-week range of traded prices to 23 Oct 2026
₹59.31Low, 30 Mar 2026₹159.81High, 12 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹677 Cr1,933rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 6 Aug 2026
- 183.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 19 May 2026
- 2.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 6 Aug 2026
- 1.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 6 Aug 2026
- 1.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 19 May 2026
- 0.42
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,16,71445.7% delivered
Who owns Zim Laboratories, filing by filing
Per cent of the company's shares. Every filing on record, from Jun 2018; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters30.30%
- Foreign institutions0.17%
- Indian institutions1.19%
- Individuals and others68.34%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Foreign institutions
- Indian institutions
- Individuals and others
| Per cent | Jun 2018Filed 19 Jul | Sep 2018Filed 19 Oct | Dec 2018Filed 18 Jan | Mar 2019Filed 21 Apr | Jun 2019Filed 22 Jul | Sep 2019Filed 22 Oct | Dec 2019Filed 13 Jan | Mar 2020Filed 8 May | Jun 2020Filed 21 Jul | Sep 2020Filed 13 Oct | Dec 2020Filed 16 Jan | Mar 2021Filed 17 Apr | Jun 2021Filed 12 Jul | Sep 2021Filed 14 Oct | Dec 2021Filed 8 Jan | Mar 2022Filed 3 Aug | Jun 2022Filed 20 Jul | Sep 2022Filed 30 Dec | Dec 2022Filed 21 Jan | Mar 2023Filed 21 Apr | Jun 2023Filed 13 Jul | Sep 2023Filed 12 Oct | Dec 2023Filed 9 Jan | Mar 2024Filed 9 Apr | Jun 2024Filed 8 Jul | Sep 2024Filed 17 Oct | Dec 2024Filed 11 Jan | Mar 2025Filed 11 Apr | Jun 2025Filed 19 Jul | Sep 2025Filed 14 Oct | Dec 2025Filed 13 Jan | Mar 2026Filed 18 Apr | Jun 2026Filed 17 Jul | Sep 2026Filed 12 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 33.52% | 33.52% | 33.52% | 33.52% | 33.39% | 33.39% | 33.39% | 33.39% | 33.39% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 30.35% | 30.36% | 30.30% | |
| Indian promoters | 33.52% | 33.52% | 33.52% | 33.52% | 33.39% | 33.39% | 33.39% | 33.39% | 33.39% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 30.35% | 30.36% | 30.30% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 66.48% | 66.48% | 66.48% | 66.48% | 66.61% | 66.61% | 66.61% | 66.61% | 66.61% | 66.74% | 66.74% | 66.74% | 66.74% | 66.74% | 66.74% | 66.74% | 66.74% | 66.74% | 66.74% | 66.74% | 66.74% | 66.74% | 66.74% | 66.74% | 66.74% | 66.74% | 66.74% | 66.74% | 66.74% | 66.74% | 66.74% | 69.65% | 69.64% | 69.70% |
| Shares in issue | 80,59,753 | 80,59,753 | 1,61,19,506 | 1,61,19,506 | 1,61,80,722 | 1,61,80,722 | 1,61,80,722 | 1,61,80,722 | 1,61,80,722 | 1,62,41,938 | 1,62,41,938 | 1,62,41,938 | 1,62,41,938 | 1,62,41,938 | 1,62,41,938 | 1,62,41,938 | 1,62,41,938 | 1,62,41,938 | 4,87,25,814what Shares in issue, Dec 2022, includes. Bonus issue on 22 Dec 2022: 2 new shares for every 1 held. Earlier filings count the shares before it. | 4,87,25,814 | 4,87,25,814 | 4,87,25,814 | 4,87,25,814 | 4,87,25,814 | 4,87,25,814 | 4,87,25,814 | 4,87,25,814 | 4,87,25,814 | 4,87,25,814 | 4,87,35,814 | 4,87,35,814 | 5,35,00,311 | 5,35,49,037 | 5,36,58,488 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | 27,62,563 | 27,62,563 | 55,25,126 | 55,25,126 | 55,25,126 | 55,25,126 | 55,25,126 | 55,25,126 | 55,25,126 | 55,25,126 | 55,25,126 | 55,25,126 | – | – | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – | 47,64,497 | 47,64,497 | 47,64,497 |
| Promoters' shares locked in | 27,01,330 | 27,01,330 | 54,02,660 | 54,02,660 | 54,02,660 | 54,02,660 | 54,02,660 | 54,02,660 | 54,02,660 | 54,02,660 | 54,02,660 | 54,02,660 | – | – | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – | – | – | – |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Zim Laboratories promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Anwar Siraj Daud, 25.03%. The filing names 13 more members with no shares.Promoter buying and selling
| Holder | ||
|---|---|---|
| Anwar Siraj DaudIndividuals and Hindu undivided families | 25.03% | 1,34,28,270 |
| Sabbah Zulfiquar KamalIndividuals and Hindu undivided families | 2.80% | 15,00,000 |
| Zulfiquar KamalIndividuals and Hindu undivided families | 2.08% | 11,15,260 |
| Hasan KamalIndividuals and Hindu undivided families | 0.19% | 1,04,400 |
| Shabbar Siraj DaudIndividuals and Hindu undivided families | 0.08% | 42,000 |
| Farhat Shabbar DaudIndividuals and Hindu undivided families | 0.07% | 38,570 |
| Tasneem Anwar DaudIndividuals and Hindu undivided families | 0.06% | 30,000 |
No promoter shares are reported as pledged.
Largest public holders of Zim Laboratories, filing by filing
Per cent, on the same shares as the split above.
| Holder | Jun 2018Filed 19 Jul | Sep 2018Filed 19 Oct | Dec 2018Filed 18 Jan | Mar 2019Filed 21 Apr | Jun 2019Filed 22 Jul | Sep 2019Filed 22 Oct | Dec 2019Filed 13 Jan | Mar 2020Filed 8 May | Jun 2020Filed 21 Jul | Sep 2020Filed 13 Oct | Dec 2020Filed 16 Jan | Mar 2021Filed 17 Apr | Jun 2021Filed 12 Jul | Sep 2021Filed 14 Oct | Dec 2021Filed 8 Jan | Mar 2022Filed 3 Aug | Jun 2022Filed 20 Jul | Sep 2022Filed 30 Dec | Dec 2022Filed 21 Jan | Mar 2023Filed 21 Apr | Jun 2023Filed 13 Jul | Sep 2023Filed 12 Oct | Dec 2023Filed 9 Jan | Mar 2024Filed 9 Apr | Jun 2024Filed 8 Jul | Sep 2024Filed 17 Oct | Dec 2024Filed 11 Jan | Mar 2025Filed 11 Apr | Jun 2025Filed 19 Jul | Sep 2025Filed 14 Oct | Dec 2025Filed 13 Jan | Mar 2026Filed 18 Apr | Jun 2026Filed 17 Jul | Sep 2026Filed 12 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Elimath Advisors Private LimitedCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.37% | 3.17% | – | – | – | 11.46% | 10.44% | 10.43% | 10.41% |
| Zakir S ValiResident individuals, over ₹2 lakh at face value | 17.68% | 17.68% | 17.68% | 17.68% | 17.61% | 17.61% | 17.61% | 17.61% | 17.61% | 17.54% | 17.54% | 17.54% | 17.54% | 17.54% | 17.54% | 17.54% | 17.54% | 17.54% | 17.54% | 17.54% | 10.36% | 10.36% | 10.36% | 10.36% | 10.36% | 10.36% | 10.36% | 10.36% | 10.36% | 10.36% | 10.36% | 9.43% | 9.43% | 9.41% |
| Florintree Trinex LlpOther non-institutions | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 8.91% | 8.90% | 8.88% |
| Investor Education and Protection Fund Authority Ministry of Corporate AffairsInvestor education fund | – | – | – | – | – | 1.25% | 1.25% | 1.25% | 1.25% | 1.25% | 1.57% | 1.69% | 1.69% | 1.69% | 1.69% | 1.69% | 2.78% | 2.78% | 2.78% | – | – | – | – | – | 3.03% | 3.03% | 3.59% | 3.59% | 3.58% | 3.58% | 3.97% | 3.60% | 3.58% | 3.57% |
| Bonanza Business Services Pvt LtdCompanies | 2.98% | 2.98% | 2.98% | 2.98% | 2.97% | 2.97% | 2.97% | 2.97% | 2.97% | 2.96% | 2.96% | 2.96% | 2.96% | 2.96% | 2.96% | 2.96% | 2.96% | 2.96% | 2.96% | 2.96% | 2.54% | 2.54% | 2.54% | 2.54% | 2.54% | 2.54% | 2.54% | 2.54% | 2.54% | 2.54% | 2.54% | 2.32% | 2.32% | 2.31% |
| Dr Iguer AbdelmounaimForeign nationals | 2.41% | 2.41% | 2.41% | 2.41% | 2.40% | 2.40% | 2.40% | 2.40% | 2.40% | 2.39% | 2.39% | 2.39% | 2.39% | 2.39% | 2.39% | 2.39% | 2.39% | 2.39% | 2.39% | 2.39% | 2.39% | 2.39% | 2.39% | 2.39% | 2.39% | 2.39% | 2.39% | 2.39% | 2.39% | 2.39% | 2.39% | 2.18% | 2.18% | 2.17% |
| Quince Infotech and Leasing Private LimitedCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.27% |
| Laadki Trading and Investments LimitedCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.37% | 1.37% | 1.37% | 1.35% | 1.35% | 1.35% | 1.23% | 1.23% | 1.23% |
| Jyoti Bharat ShethResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.38% | 1.38% | 1.38% | 1.35% | 1.35% | 1.35% | 1.23% | 1.23% | 1.23% |
| Elizabeth MathewResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | 21.86% | 21.86% | 21.86% | – | – | – | – | – | – | – | – | – | – | – | – | 12.02% | 12.02% | 8.33% | – | – | – | – |
| Mathew CyriacResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 21.86% | 21.86% | 21.86% | 21.86% | 21.86% | 20.67% | 17.46% | 16.84% | 14.58% | 14.16% | 9.83% | 9.83% | – | – | 3.22% | – | – | – | – |
| Dhoot Industrial Finance LtdCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.35% | 1.44% | 1.44% | – | – | – | – | – |
| Yuga Stocks and Commodities Private LimitedCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.22% | – | – | – | – | – | – | – | – | – | – |
| Devang ParekhResident individuals, over ₹2 lakh at face value | 2.27% | 2.27% | 2.27% | 2.27% | 2.26% | 2.26% | 2.26% | 2.26% | 2.26% | 2.13% | 2.13% | 2.13% | 1.82% | 1.82% | 1.82% | 1.82% | 1.51% | 1.51% | 1.51% | 1.51% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Anil Satyadeo DhediaResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.53% | 1.53% | 1.53% | 1.41% | 1.29% | 1.24% | 1.24% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Saif Health Remedies Private LimitedCompanies | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.34% | 1.43% | 1.42% | 1.42% | 1.42% | 1.42% | 1.42% | 1.42% | 1.42% | 1.42% | 1.42% | 1.02% | 1.02% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Zim Laboratories Limited Unclaimed Suspense AccountOther non-institutions | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.89% | 1.89% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Anil DhediaResident individuals, over ₹2 lakh at face value | 2.54% | 2.54% | 2.54% | 2.54% | 2.53% | 2.53% | 2.53% | 2.53% | 2.50% | 2.15% | 2.17% | 2.17% | 1.84% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| AA Development Capital India Fund 1, LlcOther non-institutions | 22.12% | 22.12% | 22.12% | 22.12% | 22.03% | 22.03% | 22.03% | 22.03% | 22.03% | 21.95% | – | 21.95% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| AA Development Capital Fund India LLCOther non-institutions | – | – | – | – | – | – | – | – | – | – | 21.95% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.